LBI-HTA - Publications - Search - Horizon Scanning in Oncology: Results of the 19th Prioritisation – 2nd quarter 2014

Breuer, J. and Nachtnebel, A. (2014): Horizon Scanning in Oncology: Results of the 19th Prioritisation – 2nd quarter 2014. HSO: 19th Prioritisation.

[img]PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
413Kb
Abstract

For the 19th prioritisation (May 2014), 11 were filtered out of 149 identified drugs and were sent to prioritisation. Of these, 6 drugs were ranked as ‘highly relevant’ by the expert panel, 3 as ‘relevant’ and 2 as ‘not relevant’. For ‘highly relevant’ drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.

Item Type:DSD: Horizon Scanning in Oncology
Subjects:WB Practice of medicine > WB 300-962 Therapeutics
QZ Pathology > QZ 200-380 Neoplasms.Cysts
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
Language:English
Series Name:HSO: 19th Prioritisation
Deposited on:17 Jul 2014 18:53
Last Modified:05 Aug 2016 19:42

Repository Staff Only: item control page